- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07653841
Perturbation Based Balance Training Versus Progressive Neuromuscular Training as an Adjunct to Conventional Physiotherapy for Pain Reduction and Functional Improvement in Knee Osteoarthritis
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sidra Hanif, DPT, MSNMPT, PhD PT
- Phone Number: +923335985631
- Email: sidra.hanif@uipt.iiui.edu.pk
Study Contact Backup
- Name: Rashid Nawaz, DPT, MSPT MSK
- Phone Number: +923160534195
- Email: nawazrashid158@gmail.com
Study Locations
-
-
ICT
-
Islamabad, ICT, Pakistan
- Recruiting
- Institute of Medical Rehabilitation (IMR)
-
Contact:
- Rashid Nawaz, DPT, MSPT MSK
- Phone Number: +923160534195
- Email: nawazrashid158@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Male and female, aged between 40-70 years Diagnosed with knee osteoarthritis Grades I-III based on the Kellgren-Lawrence classification Chronic knee pain for ≥3 months Ability to walk independently
Exclusion Criteria:
Grade IV osteoarthritis Previous knee surgery or joint replacement Rheumatoid arthritis or inflammatory joint disease Recent intra-articular injection (<6 months) Severe systemic illness, Neurological disorders and Vestibular disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Perturbation-Based Balance Training (PBBT)
Perturbation-Based Balance Training (PBBT) Static standing with manual perturbations: Therapist gives gentle pushes at pelvis/shoulders (anterior/posterior) Double-leg stance on foam: Maintain balance on a soft surface Tandem stance: Heel-to-toe standing with minimal support Supported balance board: Controlled weight shifting Weight-shift training: Side-to-side and forward-backward shifts
|
3 sessions/week 20-25 min (2 sets × 30 sec/activity) Starts with Low-Moderate (slow, predictable external perturbations) progress to Moderate-High (fast, unpredictable perturbations) 30-35 min (3 sets × 45-60 sec)
Other Names:
|
|
Active Comparator: Progressive Neuromuscular Training (NMT)
Progressive Neuromuscular Training (NMT) Mini squats: Partial range knee flexion (0-30°) Sit-to-stand: From chair, controlled movement Double-leg stance balance: Eyes open → progress to reduced support Tandem walking: Straight line walking Heel-to-toe walking: Improves gait control Basic coordination drills: Marching in place
|
3 sessions/week 20-25 min (2 sets × 10-12 reps) starts with Low-Moderate (RPE 9-11) then proceeds to Moderate (RPE 11-13)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain & Functional Ability
Time Frame: Baseline to Week 6
|
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
|
Baseline to Week 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Mobility
Time Frame: Baseline to Week 6
|
Functional Mobility will be measured using Time Up & Go test
|
Baseline to Week 6
|
|
Muscle strength
Time Frame: Baseline to week 6
|
Handheld Dynamometer
|
Baseline to week 6
|
|
Balance
Time Frame: Baseline to week 6
|
Functional Reach Test
|
Baseline to week 6
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIUI/RERC/ADT/2026/05/259
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.